Respondents from large companies: n=61, from small/mid: n=86
Method of interview
Panel survey
Supplementary notes
The respondents are working for pharma, biopharma, or
biotech companies; they have drug development decision-making responsibility and
are director-level or above; they work in a role related to drug development; their companies have at least one compound in development; they are from the US/Canada, Europe, and Asia.
Original question: "Using the scale provided, please indicate how likely your company is to outsource each
of the below drug development activities in the next 2 years?"
Citation formats
Likelihood of outsourcing drug development activities by biopharma companies 2025
According to a survey conducted in 2025, almost of surveyed biopharma executives stated that it is extremely likely or very likely that their company will outsource patient recruitment within the next two years. Meanwhile, closer to ** percent of biopharma executives are very likely to outsource clinical data management within the coming two years.Â
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Thermo Fisher (PPD). (February 17, 2026). Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2025 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 26, 2026, from /statistics/1414301/outsourcing-drug-development-activities-by-companies/
Thermo Fisher (PPD). "Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2025." Chart. February 17, 2026. ÌÇÐÄÆƽâ°æ. Accessed July 26, 2026. /statistics/1414301/outsourcing-drug-development-activities-by-companies/
Thermo Fisher (PPD). (2026). Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2025. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 26, 2026. /statistics/1414301/outsourcing-drug-development-activities-by-companies/
Thermo Fisher (PPD). "Likelihood of Outsourcing Select Drug Development Activities in The next 2 Years among Biopharmaceutical Companies Worldwide as of 2025." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 17 Feb 2026, /statistics/1414301/outsourcing-drug-development-activities-by-companies/
Thermo Fisher (PPD), Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2025 ÌÇÐÄÆƽâ°æ, /statistics/1414301/outsourcing-drug-development-activities-by-companies/ (last visited July 26, 2026)
Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2025 [Graph], Thermo Fisher (PPD), February 17, 2026. [Online]. Available: /statistics/1414301/outsourcing-drug-development-activities-by-companies/
